Engineered blood cells were able to alleviate and prevent symptoms of type I diabetes (T1D) and multiple sclerosis (MS), two of the more common autoimmune diseases, by inducing immune tolerance to antigens.
To continue reading subscribe now to Science News
Learn More about Science News
Already a subscriber? Sign In or Buy now to activate your subscription
